This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Telaprevir-basierte Therapie bei HCV-infizierten G1-Patienten, die auf Peginterferon/Ribavirin als Nullresponder, partielle Responder oder Relapser reagiert hatten: Abschlussergebnisse der REALIZE-Studie, Seminars in Musculoskeletal Radiology, May 2011, Thieme Publishing Group,
DOI: 10.1055/s-0031-1279879.
You can read the full text:
The following have contributed to this page
